Playing both sides: Nucleophosmin between tumor suppression and oncogenesis

Journal of Cell Biology

Volumn 182, Issue 1, 2008, Pages 7-9

  Di Fiore, Pier Paolo ^a,b,c  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; DNA; FBW7 GAMMA; HISTONE; NUCLEOPHOSMIN; PROTEIN MDM2; PROTEIN P53; UBIQUITIN PROTEIN LIGASE;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; DNA DAMAGE; DNA REPAIR; DNA TRANSCRIPTION; GENETICS; MOLECULAR BIOLOGY; NOTE; NUCLEOSOME; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; RNA TRANSCRIPTION;

ANIMALS; CELL NUCLEOLUS; F-BOX PROTEINS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MICE; MUTANT PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 47549091537     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200806069     Document Type: Note

References (11)

1. Bonetti, P., T. Davoli, C. Sironi, B. Amati, P.G. Pelicci, and E. Colombo. 2008. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7γ. J. Cell Biol. 182:19-26.
2. Chen, X., L.F. Barton, Y. Chi, B.E. Clurman, and J.M. Roberts. 2007. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. Mol. Cell. 26:843-852.
3. Colombo, E., P. Bonetti, E. Lazzerini Denchi, P. Martinelli, R. Zamponi, J.C. Marine, K. Helin, B. Falini, and P.G. Pelicci. 2005. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol. Cell. Biol. 25:8874-8886.
4. Colombo, E., P. Martinelli, R. Zamponi, D.C. Shing, P. Bonetti, L. Luzi, S. Volorio, L. Bernard, G. Pruneri, M. Alcalay, and P.G. Pelicci. 2006. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res. 66:3044-3050.
5. Falini, B., C. Mecucci, E. Tiacci, M. Alcalay, R. Rosati, L. Pasqualucci, R. La Starza, D. Diverio, E. Colombo, A. Santucci, et al. 2005. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 352:254-266.
6. Grisendi, S., R. Bernardi, M. Rossi, K. Cheng, L. Khandker, K. Manova, and P.P. Pandolfi. 2005. Role of nucleophosmin in embryonic development and tumorigenesis. Nature. 437:147-153.
7. Grisendi, S., C. Mecucci, B. Falini, and P.P. Pandolfi. 2006. Nucleophosmin and cancer. Nat. Rev. Cancer. 6:493-505.
8. Mariano, A.R., E. Colombo, L. Luzi, P. Martinelli, S. Volorio, L. Bernard, N. Meani, R. Bergomas, M. Alcalay, and P.G. Pelicci. 2006. Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal. Oncogene. 25:4376-4380.
9. Minella, A.C., and B.E. Clurman. 2005. Mechanisms of tumor suppression by the SCF(Fbw7). Cell Cycle. 4:1356-1359.
10. Thompson, B.J., V. Jankovic, J. Gao, S. Buonamici, A. Vest, J.M. Lee, J. Zavadil, S.D. Nimer, and I. Aifantis. 2008. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205:1395-1408.
11. Yada, M., S. Hatakeyama, T. Kamura, M. Nishiyama, R. Tsunematsu, H. Imaki, N. Ishida, F. Okumura, K. Nakayama, and K.I. Nakayama. 2004. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 23:2116-2125.